WP
GILD icon

Wedgewood Partners’s Gilead Sciences GILD Stock Holding History

Wedgewood Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,907,287
Closed -$135M – 22
2014
Q1 		$135M Buy
1,907,287
+106,303
+6% +$8.34M 2.5% 19
2013
Q4 		$135M Sell
1,800,984
-712,930
-28% -$49.6M 2.81% 20
2013
Q3 		$158M Buy
2,513,914
+54,402
+2% +$3.25M 3.79% 16
2013
Q2 		$126M Buy
+2,459,512
New +$128M 3.64% 15

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wedgewood Partners's GILD Position: Q2 2014 in Review

Wedgewood Partners sold out of Gilead Sciences (GILD) in Q2 2014, closing a stake of 1,907,287 shares — an estimated $135M sold.

Wedgewood Partners first reported a position in GILD in Q2 2013 and held it in 4 quarters. The position peaked at $158M in Q3 2013. 1,262 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

  • Wedgewood Partners reported no remaining Gilead Sciences position as of Q2 2014 after selling out during the quarter.
  • Wedgewood Partners sold 1,907,287 Gilead Sciences shares in Q2 2014, an estimated $135M.
  • Wedgewood Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 4 quarters.
  • Wedgewood Partners's Gilead Sciences position peaked at $158M in Q3 2013.
  • 1,262 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Wedgewood Partners's 13F filing for Q2 2014, filed 14 Aug 2014.